These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9054646)
21. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus. Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721 [TBL] [Abstract][Full Text] [Related]
24. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study. Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663 [TBL] [Abstract][Full Text] [Related]
25. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
26. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Matsuda J; Saitoh N; Gohchi K; Gotoh M; Tsukamoto M Am J Hematol; 1994 Sep; 47(1):56-8. PubMed ID: 8042617 [TBL] [Abstract][Full Text] [Related]
27. Significance of antiphospholipid antibodies in lupus nephritis. Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463 [TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus. Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891 [TBL] [Abstract][Full Text] [Related]
29. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123 [TBL] [Abstract][Full Text] [Related]
30. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
32. [Clinico-immunological aspects of antiphospholipid syndrome]. Reshetniak TM; Alekberova ZS; Aleksandrova EN Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468 [TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681 [TBL] [Abstract][Full Text] [Related]
34. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207 [TBL] [Abstract][Full Text] [Related]
36. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633 [TBL] [Abstract][Full Text] [Related]
37. [Lupus anticoagulants in patients with systemic lupus erythematosus]. Matsuura Y; Nawata Y; Miike S; Hiraguri M; Kita Y; Kurasawa K; Takabayashi K; Oh H; Iwamoto I; Saito Y Ryumachi; 1996 Feb; 36(1):16-24. PubMed ID: 8711533 [TBL] [Abstract][Full Text] [Related]
38. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus. Wong KL; Liu HW; Ho K; Chan K; Wong R J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies. Obermoser G; Bitterlich W; Kunz F; Sepp NT Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914 [TBL] [Abstract][Full Text] [Related]
40. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome. Guglielmone HA; Fernandez EJ J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]